Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Montse Blanco"'
Autor:
Karen Fernández, Paloma Candela, Montse Blanco, Andrea Hernández-Martínez, Yolanda Sánchez-Matas
Publikováno v:
Educación con perspectiva de género. ISBN: 9788411226851
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6e942d05d57f1508fec551049f0bf26
https://doi.org/10.2307/j.ctv36k5c46.39
https://doi.org/10.2307/j.ctv36k5c46.39
Autor:
Raul Embun, Juan J. Rivas de Andrés, Sergi Call, Beatriz de Olaiz Navarro, Jorge L. Freixinet, Sergio Bolufer, Jose R. Jarabo, Nuria Pajuelo, Laureano Molins, Juan J. Rivas, Francisco Rivas-Doyague, Jorge Hernández-Ferrández, Félix Heras, Javier de la Cruz, Matilde Rubio, Esther Fernández, Miguel Carbajo, Rafael Peñalver, José R. Jarabo, Diego González-Rivas, Carlos Pagés, David Smith, Richard Wins, Antonio Arnau, Andrés Arroyo, Carmen Marrón, Akiko Tamura, Montse Blanco, Beatriz de Olaiz, Gemma Muñoz, José M. García Prim, Carlos Rombolá, Santiago García-Barajas, Alberto Rodríguez-Fuster, Javier Ruiz-Zafra, Guillermo Carriquiry, Moisés Rosenberg, Emilio Canalís
Publikováno v:
The Annals of Thoracic Surgery. 101:1883-1890
Background Although numerous existing studies have analyzed the prognostic factors of patients who have had surgical intervention for lung metastases of colorectal carcinoma (CRC), many of the results obtained until now have been contradictory. As a
Autor:
Antonio Arnau, Carlos Rombolá, Juan J. Fibla, Akiko Tamura, Rafael Peñalver, José M. Mier, José Ramón Jarabo, J.J. Rivas, Guillermo Carriquiry, Félix Heras, Juan J. Rivas, Emilio Canalís, Santiago García Barajas, F. Rivas, David R. Smith, Montse Blanco, Alberto Rodríguez, Laureano Molins, Sergi Call, R. Embun, Moisés Rosenberg, Richard Wins, Javier de la Cruz, J M Hernández, Raul Embun, J. Hernández, Federico Gómez de las Heras, L. Molins, M. Carmen Marron, Esther Fernández, Jorge Freixinet, Gemma Muñoz, Beatriz de Olaiz, Diego Gonzalez-Rivas, Miguel Carbajo Carbajo, Andrés Arroyo, Javier Ruiz, M. Rubio, Sergio Bolufer, José M. García Prim, Carlos Pagás
Publikováno v:
Annals of Oncology. 27:850-855
BACKGROUND Patients with pulmonary metastases from colorectal cancer (CRC) may benefit from aggressive surgical therapy. The objective of this study was to determine the role of major anatomic resection for pulmonary metastasectomy to improve surviva
Autor:
Beatriz de Olaiz, Emilio Canalís Arrayas, José Manuel Mier Odriozola, Carlos E. Garcia Franco, Montse Blanco Ramos, Richard Wins, José M. García Prim, Moisés Rosenberg, Jorge Freixinet, Javier Ruiz Zafra, Juan Manuel Córcoles Padilla, Carlos Pagés Navarrete, Guillermo Carriquiry, Félix Heras, Sergi Call, Juan J. Rivas de Andrés, Esther Fernández Araujo, Carlos Rombolá, Miguel Carbajo Carbajo, Juan José Rivas de Andrés, Alberto Rodríguez-Fuster, Rafael Peñalver Pascual, Laureano Molins, Raul Embun, José Belda-Sanchis, José Ramón Jarabo Sarceda, Sergi Mojal, Santiago García Barajas, Matilde Rubio Garay, D.C. Smith, Rafael Aguiló, Andrés Arroyo Tristán, Javier de la Cruz Lozano, Raul Embún Flor, Francisco Rivas Doyague, Mª Carmen Marrón Fernández, Gemma Muñoz Molina, D. González, Antonio Arnau
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 45(4)
OBJECTIVE: Little information is available on postoperative morbidity and mortality after pulmonary metastasectomy. We describe the postoperative morbidity and mortality in a large multicentre series of patients after a first surgical procedure for p
Autor:
María Sanjurjo-Sáez, Andrés Muñoz, Eva González-Haba, Lucia Cortejoso-Fernandez, Luis A. López-Fernández, Miguel Martín, Maria-Isabel Garcia-Garcia, Montse Blanco Codeisido, Pilar Alfonso, Daniel Lopez-Trabada Ataz
Publikováno v:
Journal of Clinical Oncology. 31:390-390
390 Background: 5-fluorouracil and capecitabine are the gold standards in colorectal cancer (CRC) treatment and are often combined with oxaliplatin (FOLFOX and XELOX chemotherapy, respectively). Our purpose was to analyze associations between severe
Autor:
Miguel Martín, M. Carmen Riesco, Pilar Alfonso, Ana Belen Ruperez Blanco, Sara Custodio Cabello, Sonsoles Alvarez, Rebeca Mondejar Solís, Gonzalo Tapia, Andres J. Muñoz Martín, Montse Blanco Codeisido
Publikováno v:
Journal of Clinical Oncology. 30:e14058-e14058
e14058 Background: Patients with colorectal cancer (CRC) and liver metastases have a poor prognosis, only a small proportion has initially resectable metastases. Bevacizumab (BEV) added to chemotherapy (CT) is active for metastatic CRC. This study ai